© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Repligen Corporation (RGEN) shows an Average True Range (ATR) of 5.41 and an Enterprise Value of 9.32B. Its average trading volume over the past 3 months is 886.73K, indicating liquidity. These fundamental metrics provide insight into RGEN's underlying financial health and market activity.
Repligen Corporation (RGEN) technical indicators as of December 22, 2025: the SMA 20 is -0.76%, SMA 50 at 3.71%, and SMA 200 at 20.5%. The RSI 14 value is 54.34, suggesting its current momentum. These technical analysis signals help assess RGEN's price trends and potential future movements.
Repligen Corporation (RGEN) stock performance overview as of December 22, 2025: The 52-week high is $182.52 (currently -11.03% below), and the 52-week low is $102.97 (currently 57.7% above). Over the past year, RGEN's performance is 3.82%, compared to the S&P 500's 12.87% change.
According to market data, Repligen Corporation (RGEN) stock's recent performance metrics show that over the last month, RGEN is 6.09%, with a Year-to-Date (YTD) performance of 12.81%. Over the past year, the stock has seen a 3.82% change. These figures summarize RGEN's price movements across various periods, reflecting its historical returns.
According to current financial data, RGEN stock's P/E (TTM) ratio is 5251.47, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for RGEN, including P/S (12.91), P/B (4.38), and P/FCF (86.62), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.